Needham & Company Starts Pluristem Therapeutics (PSTI) at Buy; Leading Cell Therapy Platform
Go back to Needham & Company Starts Pluristem Therapeutics (PSTI) at Buy; Leading Cell Therapy Platform| PLURISTEM THERAPEUTICS, Inc. (NASDAQ: PSTI) | Delayed: 1.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.00 | 52 Week High | $1.85 | |||
| Open | $0.00 | 52 Week Low | $0.71 | |||
| Day High | $1.00 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $-0.41 | |||
| Volume | 12 | |||||
